Retrieve available abstracts of 148 articles: HTML format
Single Articles
July 2025
WU HL, Yang R, Liang XL, Ma R, et al Clinical Significance of Tumor-Infiltrating Lymphocytes in Malignant Peritoneal
Mesothelioma: A Single-Center Study of 143 Cases.
Ann Surg Oncol. 2025;32:5051-5062. PubMedAbstract available
TANG WF, Qiu ZB, Chu XP, Zeng YM, et al EGFR Mutation Rates Correlate with Age at Diagnosis and Tumor Characteristics in
Patients with Pulmonary Ground-Glass Opacities.
Ann Surg Oncol. 2025;32:4641-4649. PubMedAbstract available
June 2025
KHAN AA, Shah SK, Basu S, Alex GC, et al ASO Visual Abstract: Thoracic Adipose Volume is Associated with Occult Nodal
Disease- and Disease-Free Survival in Females with Clinically Node Negative
Non-Small Cell Lung Cancer.
Ann Surg Oncol. 2025 Jun 14. doi: 10.1245/s10434-025-17634. PubMed
LI Z, Wu J, Chen C, Liu C, et al ASO Visual Abstract: Longitudinal Trajectory of Patient-Reported Fatigue in
Patients Undergoing Thoracoscopic Lung Cancer Surgery.
Ann Surg Oncol. 2025 Jun 9. doi: 10.1245/s10434-025-17574. PubMed
KHAN AA, Shah SK, Basu S, Alex GC, et al Thoracic Adipose Volume is Associated with Occult Nodal Disease and Disease-Free
Survival in Females with Clinically Node-Negative Non-Small Cell Lung Cancer.
Ann Surg Oncol. 2025 Jun 3. doi: 10.1245/s10434-025-17485. PubMedAbstract available
HASHINOKUCHI A, Kinoshita F, Iimori M, Kosai K, et al DNA Polymerase Delta 2 Activates Cell Cycle in Lung Adenocarcinoma, Leading to
High Malignancy and Poor Prognosis.
Ann Surg Oncol. 2025;32:4487-4496. PubMedAbstract available
SINGH A, Xie Y, Mazzola E, Wang S, et al Gait Speed as a Measure of Frailty and Outcomes After Lung Resection.
Ann Surg Oncol. 2025;32:4181-4188. PubMedAbstract available
May 2025
NAEEM W, Khan AA, Adebayo OW, Ansari M, et al ASO Visual Abstract: Difficult Decisions in the Multidisciplinary Treatment of
Resectable Non-small Cell Lung Cancer.
Ann Surg Oncol. 2025 May 26. doi: 10.1245/s10434-025-17521. PubMed
NAEEM W, Khan AA, Seder CW ASO Author Reflections: Controversies at the Tumor Board-The Gray Areas in the
Multimodality Treatment of Resectable Non-small Cell Lung Cancer.
Ann Surg Oncol. 2025 May 19. doi: 10.1245/s10434-025-17459. PubMed
LI Z, Wu J, Chen C, Liu C, et al Longitudinal Trajectory of Patient-Reported Fatigue in Patients Undergoing
Thoracoscopic Lung Cancer Surgery.
Ann Surg Oncol. 2025 May 17. doi: 10.1245/s10434-025-17444. PubMedAbstract available
SU XE, Lin CL, Wang HG, Jing-Liu, et al Development and Validation of a Machine Learning-Based Predictive Model for
Postoperative Frailty in Patients with Non-Small Cell Lung Cancer and Its
Relation to Early Recovery.
Ann Surg Oncol. 2025 May 14. doi: 10.1245/s10434-025-17353. PubMedAbstract available
April 2025
NAEEM W, Khan AA, Adebayo OW, Ansari M, et al Difficult Decisions in the Multidisciplinary Treatment of Resectable Non-small
Cell Lung Cancer.
Ann Surg Oncol. 2025 Apr 28. doi: 10.1245/s10434-025-17345. PubMedAbstract available
UEDA D, Mimae T, Kamigaichi A, Tsubokawa N, et al Prognostic Benefit of Segmentectomy for Patients with Low Muscle Mass in
Early-Stage Lung Cancer.
Ann Surg Oncol. 2025 Apr 24. doi: 10.1245/s10434-024-16384. PubMedAbstract available
ASAMURA H, Yotsukura M, Rami-Porta R, Rusch VW, et al Updates on the Version 9 American Joint Committee on Cancer Staging System for
Lung Cancer.
Ann Surg Oncol. 2025 Apr 15. doi: 10.1245/s10434-025-17327. PubMed
MATSUDO K, Takada K, Hashinokuchi A, Nagano T, et al Significance of Tumor Microvasculature in the Tumor Microenvironment in
Adenocarcinoma with EGFR Common Mutations.
Ann Surg Oncol. 2025;32:3031-3039. PubMedAbstract available
LIANG XL, Su YD, Li XB, Fu YB, et al Prognostic Factors of Long-Term Survival and Conditional Survival Analysis in MPM
Patients Treated with CRS+HIPEC: A Retrospective Study of Two Centers.
Ann Surg Oncol. 2025;32:2912-2922. PubMedAbstract available
CHEN PH, Chen C, Lu CW, Lu TP, et al Tumor Spread Through Air Spaces Predicts Survival in Resected Pulmonary
Lymphoepithelial Carcinoma.
Ann Surg Oncol. 2025;32:2675-2686. PubMedAbstract available
March 2025
JENKINS JA, Aly MR, Farina JM, Khedr A, et al ASO Visual Abstract: Money Matters-The Effect of Income on Postsurgical Outcomes
in Stage IA Non-small Cell Lung Cancer.
Ann Surg Oncol. 2025 Mar 30. doi: 10.1245/s10434-025-17240. PubMed
BANKS KC, Sarovar V, Sun A, Wile RK, et al ASO Visual Abstract: The Impact of Preoperative Invasive Nodal Staging on
Unexpected Mediastinal Upstaging in Early Stage Non-small Cell Lung Cancer.
Ann Surg Oncol. 2025 Mar 26. doi: 10.1245/s10434-025-17213. PubMed
LAMPA E, Boros M, Berglund A, Wagenius G, et al Timing of Adjuvant Chemotherapy After Surgical Resection for Non-small Cell Lung
Cancer: A Target Trial Emulation Using Nationwide Swedish Registry Data.
Ann Surg Oncol. 2025 Mar 19. doi: 10.1245/s10434-025-17193. PubMedAbstract available
JENKINS JA, Aly MR, Farina JM, Khedr A, et al Money Matters: The Effect of Income on Postsurgical Outcomes in Stage IA
Non-small Cell Lung Cancer.
Ann Surg Oncol. 2025 Mar 12. doi: 10.1245/s10434-025-17107. PubMedAbstract available
MADEKA I, Mack SJ, Rshaidat H, Ishwar A, et al Medicaid Expansion is Associated with Differences in Local Therapy for Non-small
Cell Lung Cancer.
Ann Surg Oncol. 2025 Mar 5. doi: 10.1245/s10434-025-17082. PubMedAbstract available
WATERS J, Molena D Recent Noteworthy Studies in Thoracic Oncology.
Ann Surg Oncol. 2025;32:1610-1616. PubMedAbstract available
BASKIN AS, Burapachaisri K, Guha S, Velotta JB, et al The Landmark Series: Advances in Preoperative Mediastinal Lymph Node Staging for
Non-small Cell Lung Cancer (NSCLC).
Ann Surg Oncol. 2025 Mar 1. doi: 10.1245/s10434-025-17008. PubMedAbstract available
February 2025
BANKS KC, Sarovar V, Sun A, Wile RK, et al The Impact of Preoperative Invasive Nodal Staging on Unexpected Mediastinal
Upstaging in Early-Stage Non-small Cell Lung Cancer.
Ann Surg Oncol. 2025 Feb 20. doi: 10.1245/s10434-025-17034. PubMedAbstract available
BASKIN AS, Velotta JB ASO Author Reflections: Preoperative Mediastinal Lymph Node Staging for Non-small
Cell Lung Cancer: Where Do We Go from Here?
Ann Surg Oncol. 2025 Feb 17. doi: 10.1245/s10434-025-17035. PubMed
HUANG Y, Zeng H, Zhang G, Ren F, et al Pooled Analysis of the Prognostic Significance of Epidermal Growth Factor
Receptor (EGFR) Mutational Status in Combination with Other Driver Genomic
Alterations in Stage I Resected Invasive Lung Adenocarcinoma for Recurrence-Free
Survival: A Populatio
Ann Surg Oncol. 2025;32:760-770. PubMedAbstract available
KHAN MMM, Khalil M, Stecko H, Pawlik TM, et al Disparities in Next-Generation Genetic Sequencing Among Individuals with Cancer.
Ann Surg Oncol. 2025;32:650-652. PubMedAbstract available
January 2025
MANISUNDARAM N, Ragan MV, Mayon L, Vaporciyan A, et al ASO Visual Abstract: Surgical Margins and Oncologic Outcomes Following Wedge
Resection of Pulmonary Metastases in Pediatric and Young Adult Sarcoma Patients.
Ann Surg Oncol. 2025 Jan 29. doi: 10.1245/s10434-025-16900. PubMed
AKAMINE T, Wakasu S, Matsubara T, Yamaguchi M, et al ASO Visual Abstract: Is Sublobar Resection Feasible for High-Risk Pathological
Stage I Non-small Cell Lung Cancer?
Ann Surg Oncol. 2025 Jan 27. doi: 10.1245/s10434-025-16907. PubMed
SIRAKAYA F, Calik Kutukcu E, Onur MR, Dikmen E, et al Re: The Effects of Various Approaches to Lobectomies on Respiratory Muscle
Strength, Diaphragm Thickness, and Exercise Capacity in Lung Cancer Re: Enhancing
Respiration Function Evaluation and Recovery in Lung Cancer: The
Interdisciplinary Approach to
Ann Surg Oncol. 2025 Jan 22. doi: 10.1245/s10434-024-16865. PubMed
MANISUNDARAM N, Ragan MV, Mayon L, Vaporciyan A, et al Surgical Margins and Oncologic Outcomes Following Wedge Resection of Pulmonary
Metastases in Pediatric and Young Adult Patients with Sarcoma.
Ann Surg Oncol. 2025 Jan 9. doi: 10.1245/s10434-024-16800. PubMedAbstract available
LI Z, He Z, Xu W, Pan X, et al The Necessity of Lymphadenectomy for Non-Small Cell Lung Cancer Smaller Than 6 mm
in Solid Size.
Ann Surg Oncol. 2025 Jan 9. doi: 10.1245/s10434-024-16675. PubMedAbstract available
December 2024
ZHANG B, Xia L, Zhu X, Zhang L, et al Enhancing Respiration Function Evaluation and Recovery in Lung Cancer: The
Interdisciplinary Approach to Postoperative Management.
Ann Surg Oncol. 2024 Dec 29. doi: 10.1245/s10434-024-16733. PubMedAbstract available
AKAMINE T, Wakasu S, Matsubara T, Yamaguchi M, et al Is Sublobar Resection Feasible for High-Risk Pathologic Stage I Non-small Cell
Lung Cancer?
Ann Surg Oncol. 2024 Dec 16. doi: 10.1245/s10434-024-16700. PubMedAbstract available
PACHIMATLA AG, Gee K, Hsiao HH, Yendamuri S, et al Image-Based Measures of Obesity are Associated with Alterations in Metabolic
Pathways in Non-small Cell Lung Cancer.
Ann Surg Oncol. 2024 Dec 13. doi: 10.1245/s10434-024-16402. PubMedAbstract available
LIU J, Cao B, Shi Z, Liu X, et al Correlation Between the Number of Pathological Risk Factors and Postoperative
Prognosis in Patients with Stage I Lung Adenocarcinoma.
Ann Surg Oncol. 2024;31:9310-9320. PubMedAbstract available
XIANG Y, Zhou K, Fang C, Han W, et al Impact of Tumor Size and Differentiation Grade on Survival After Lobectomy and
Segmentectomy for Patients with Early-Stage Lung Adenocarcinoma.
Ann Surg Oncol. 2024;31:9289-9297. PubMedAbstract available
November 2024
WEI X, Liu J, Cao B, Shi Q, et al Image-Based Assessment of Obesity and Metabolic Pathway Alterations in Non-small
Cell Lung Cancer.
Ann Surg Oncol. 2024 Nov 29. doi: 10.1245/s10434-024-16617. PubMed
LIU W, Yue D, Zhang B ASO Author Reflections: The Candidate Biomarkers for Predicting Neoadjuvant
Immunotherapy in Resectable Non-small Cell Lung Cancer.
Ann Surg Oncol. 2024 Nov 15. doi: 10.1245/s10434-024-16150. PubMed
UEDA D, Mimae T, Okada M ASO Author Reflections: Surgical Procedures for Early-Stage Lung Cancer Patients
with Low Muscle Mass.
Ann Surg Oncol. 2024 Nov 15. doi: 10.1245/s10434-024-16481. PubMed
GONG S, Li G, Wu B Prognostic Role of Emphysema in Surgical Stage I Non-small Cell Lung Cancer.
Ann Surg Oncol. 2024 Nov 8. doi: 10.1245/s10434-024-16427. PubMed
KAR M The Impact of Sarcopenia on Outcomes in Video-Assisted Thoracoscopic Surgery
(VATS) for Lung Cancer.
Ann Surg Oncol. 2024 Nov 7. doi: 10.1245/s10434-024-16447. PubMed
HONG Q, Chen H, Yi H, Mu J, et al Virtual Reality: Pioneering the Future of Precision in Anatomical Partial
Lobectomy.
Ann Surg Oncol. 2024;31:7665-7667. PubMed
WU J, Li C, Liu C Uniportal Thoracoscopic Complex Combined Seg-Sub-subsegmentectomy of RS9+10bii:
Dual-Display Method and Combined Approaches (Trans-fissure and Trans-ligament).
Ann Surg Oncol. 2024;31:7775-7776. PubMedAbstract available
NAKAMURA A, Hashimoto M, Kuroda A, Takegahara K, et al Peritoneal Dissemination in Patients with Recurrence After
Post-pleurectomy/decortication for Pleural Mesothelioma.
Ann Surg Oncol. 2024;31:7767-7774. PubMedAbstract available
October 2024
KAO TN, Chiang XH, Kuo SW, Huang PM, et al ASO Visual Abstract: Comparative Analyses of the Outcomes Between Lobectomies and
Trisegmentectomies/Lingulectomies in the Surgical Management of Clinical Stage I
Left Upper Lobe Non-small Cell Lung Cancer.
Ann Surg Oncol. 2024 Oct 31. doi: 10.1245/s10434-024-16394. PubMed
KAO TN, Chiang XH, Kuo SW, Huang PM, et al Comparative Analyses of the Outcomes Between Lobectomies and
Trisegmentectomies/Lingulectomies in the Surgical Management of Clinical Stage I
Left Upper Lobe Non-small Cell Lung Cancer.
Ann Surg Oncol. 2024 Oct 24. doi: 10.1245/s10434-024-16338. PubMedAbstract available
NAKAMURA A, Hashimoto M, Funaki S, Hasegawa S, et al ASO Author Reflections: Postoperative Peritoneal Dissemination Recurrence of
Pleural Mesothelioma has a Poor Prognosis.
Ann Surg Oncol. 2024;31:6729-6730. PubMed
LIU J, Cao B, Shi Z, Liu X, et al ASO Author Reflections: Correlation between the Number of Pathological Risk
Factors and Postoperative Prognosis in Patients with Stage I Lung Adenocarcinoma.
Ann Surg Oncol. 2024;31:6727-6728. PubMed
WU J, Liu C ASO Author Reflections: Uniportal Thoracoscopic Highly Complex Basal
Segmentectomies-Demanding Techniques are Needed.
Ann Surg Oncol. 2024;31:6720-6721. PubMed
NAGANO T, Takada K, Takenaka T, Yoshizumi T, et al ASO Author Reflections: Relationship Between SIRPalpha Expression on Tumor-Associated
Macrophages and Tumor Microenvironment in Lung Squamous Cell Carcinoma.
Ann Surg Oncol. 2024;31:6725-6726. PubMed
ROCCO G Predicting Lung Function After Segmentectomy.
Ann Surg Oncol. 2024;31:6359-6360. PubMed
OHTANI-KIM SJ, Samejima J, Wakabayashi M, Tada M, et al Effect of Resected Lung Volume on Pulmonary Function and Residual Lung Volume in
Patients Undergoing Segmentectomy: A Retrospective Study.
Ann Surg Oncol. 2024;31:6645-6651. PubMedAbstract available
September 2024
BRUNELLI A Wedge or Segmentectomy for Early-Stage Non-Small Cell Lung Cancer? The Dilemma
Remains Unresolved.
Ann Surg Oncol. 2024 Sep 23. doi: 10.1245/s10434-024-16257. PubMed
LAI Y, Dong Y, Che GW ASO Author Reflections: Prerehabilitation with High-Intensive Model for Surgical
Lung Cancer Patients.
Ann Surg Oncol. 2024 Sep 21. doi: 10.1245/s10434-024-16151. PubMed
LAI Y, Dong Y, Tian L, Li H, et al The Optimal Time of High-Intensity Pre-rehabilitation for Surgical Lung Cancer
Patients: A Retrospective Cohort Study with 4452 Patients.
Ann Surg Oncol. 2024 Sep 19. doi: 10.1245/s10434-024-16054. PubMedAbstract available
BOUTROS CS, Arora RC, Towe CW Optimizing Preoperative Rehabilitation: Shaping the Future of Lung Cancer Surgery
Outcomes.
Ann Surg Oncol. 2024 Sep 17. doi: 10.1245/s10434-024-16256. PubMed
LIU J, Qing H ASO Author Reflections: Impact of Sarcopenia on Patient-Reported Outcomes After
Video-Assisted Thoracoscopic Surgery for Lung Cancer.
Ann Surg Oncol. 2024 Sep 16. doi: 10.1245/s10434-024-16241. PubMed
OHTANI-KIM SJ, Samejima J, Wakabayashi M, Tada M, et al ASO Visual Abstract: Effect of Resected Lung Volume on Pulmonary Function and
Residual Lung Volume in Patients Undergoing Segmentectomy-A Retrospective Study.
Ann Surg Oncol. 2024;31:5783-5784. PubMed
NAGANO T, Takada K, Narutomi F, Kinoshita F, et al Clinical Significance of SIRPalpha Expression on Tumor-Associated Macrophages in
Patients with Lung Squamous Cell Carcinoma.
Ann Surg Oncol. 2024;31:6309-6319. PubMedAbstract available
YASAR S ASO Author Reflections: Analysis of Treatment Strategies and Outcomes in
Malignant Peritoneal Mesothelioma: Insights from a Multi-center Study.
Ann Surg Oncol. 2024;31:6276-6277. PubMed
OHTANI-KIM SJ, Samejima J, Wakabayashi M, Tada M, et al What is the Optimal Resection Extent for Preserving Respiratory Function in
Segmentectomy?: Insights on Lung Resection Volume and Respiratory Function.
Ann Surg Oncol. 2024;31:5766-5767. PubMed
VAN HAREN RM, Kovacic MB, Delman AM, Pratt CG, et al Disparities Associated with Decision to Undergo Oncologic Surgery: A Prospective
Mixed-Methods Analysis.
Ann Surg Oncol. 2024;31:5757-5764. PubMedAbstract available
JIA J, Zhang G, Wei L, Qi L, et al The Battle for Accuracy: Identifying the Most Effective Grading System for Lung
Invasive Mucinous Adenocarcinoma.
Ann Surg Oncol. 2024;31:5717-5728. PubMedAbstract available
FUJIWARA W, Yotsukura M, Yoshida Y, Nakagawa K, et al Clinical and Pathologic Differences between Small-Cell Carcinoma and Large-Cell
Neuroendocrine Carcinoma of the Lung.
Ann Surg Oncol. 2024;31:5697-5705. PubMedAbstract available
YASAR S, Yilmaz F, Utkan G, Algin E, et al Analysis of Treatment Strategies and Outcomes in Malignant Peritoneal
Mesothelioma: Insights From a Multi-Center Study.
Ann Surg Oncol. 2024;31:6228-6236. PubMedAbstract available
SIRAKAYA F, Calik Kutukcu E, Onur MR, Dikmen E, et al ASO Author Reflections: Is the VATS Technique Superior to Thoracotomy Techniques
in Terms of Respiratory Muscle Function and Functional Exercise Capacity?
Ann Surg Oncol. 2024;31:5768-5769. PubMed
August 2024
LIU J, Li D, Ma H, Li Y, et al Early Postoperative Patient-Reported Outcomes of Sarcopenia Versus Nonsarcopenia
in Patients Undergoing Video-Assisted Thoracoscopic Surgery for Lung Cancer.
Ann Surg Oncol. 2024 Aug 31. doi: 10.1245/s10434-024-16140. PubMedAbstract available
MOTONO N, Mizoguchi T, Ishikawa M, Iwai S, et al ASO Author Reflections: Utility of Sublobar Resection for Small-Sized Non-Small
Cell Lung Cancer.
Ann Surg Oncol. 2024 Aug 30. doi: 10.1245/s10434-024-16126. PubMed
LIU W, Chen C, Li C, Wu X, et al Comprehensive Analysis of Immune Responses to Neoadjuvant Immunotherapy in
Resectable Non-small Cell Lung Cancer.
Ann Surg Oncol. 2024 Aug 27. doi: 10.1245/s10434-024-16053. PubMedAbstract available
MOTONO N, Mizoguchi T, Ishikawa M, Iwai S, et al Accurate Selection of Sublobar Resection for Small Non-small Cell Lung Cancer.
Ann Surg Oncol. 2024 Aug 13. doi: 10.1245/s10434-024-16027. PubMedAbstract available
TANE S The Crucial Value of Glutathione Peroxidase 2 to Understand the 'Two-Faced' Role
of Reactive Oxygen Species in Lung Adenocarcinoma.
Ann Surg Oncol. 2024;31:4849-4850. PubMed
HASHINOKUCHI A, Matsubara T, Ono Y, Shunichi S, et al ASO Visual Abstract: Clinical and Prognostic Significance of Glutathione
Peroxidase 2 in Lung Adenocarcinoma.
Ann Surg Oncol. 2024;31:5098. PubMed
WOO W, Park CH, Lee J, Moon DH, et al Left Upper Division Segmentectomy Compared with Lobectomy for Lung Expansion and
Bronchus Tortuosity.
Ann Surg Oncol. 2024;31:5021-5027. PubMedAbstract available
HASHINOKUCHI A, Matsubara T, Takenaka T, Yoshizumi T, et al ASO Author Reflections: Impact of Glutathione Peroxidase 2 (GPX2) in Lung
Adenocarcinoma.
Ann Surg Oncol. 2024;31:5092-5093. PubMed
July 2024
MCGANN K, Demarest CT Lobectomy Versus Segmentectomy for Early-Stage Non-small Cell Lung Cancer: Is
Less More?
Ann Surg Oncol. 2024 Jul 30. doi: 10.1245/s10434-024-15883. PubMed
WEI W, Wang Y, Ouyang R, Wang T, et al Machine Learning for Early Discrimination Between Lung Cancer and Benign Nodules
Using Routine Clinical and Laboratory Data.
Ann Surg Oncol. 2024 Jul 16. doi: 10.1245/s10434-024-15762. PubMedAbstract available
SHAH SK, Krishnan V, Khan AA, Fass L, et al Women are Underrepresented in Non-small Cell Lung Cancer Clinical Trials: A
Systematic Review.
Ann Surg Oncol. 2024 Jul 10. doi: 10.1245/s10434-024-15720. PubMedAbstract available
SHAH SK, Khan AA, Alex GC ASO Author Reflections: Getting a Seat at the Table-A Call for Equitable
Inclusion of Women in Lung Cancer Clinical Trials.
Ann Surg Oncol. 2024 Jul 8. doi: 10.1245/s10434-024-15778. PubMed
CHEUN JH, Chung S, Han JH, Lee YW, et al Surveillance for Distant Metastasis in Breast Cancer Patients Who Underwent
Contemporary Management: A Report from the Korean Breast Cancer Society Survivor
Research Group.
Ann Surg Oncol. 2024 Jul 5. doi: 10.1245/s10434-024-15665. PubMedAbstract available
RANDLE RJ, Bhandari P, He H, Berry MF, et al Complications of Outpatient Chest Tube Management for Prolonged Air Leaks After
Pulmonary Surgery.
Ann Surg Oncol. 2024;31:4308-4316. PubMedAbstract available
SANKARAN R, O'Connor J, Nuliyalu U, Diaz A, et al Payer-Negotiated Price Variation and Relationship to Surgical Outcomes for the
Most Common Cancers at NCI-Designated Cancer Centers.
Ann Surg Oncol. 2024;31:4339-4348. PubMedAbstract available
HASHINOKUCHI A, Matsubara T, Ono Y, Shunichi S, et al Clinical and Prognostic Significance of Glutathione Peroxidase 2 in Lung
Adenocarcinoma.
Ann Surg Oncol. 2024;31:4822-4829. PubMedAbstract available
June 2024
LI X, Fan F, Chen H ASO Author Reflections: Long-Term Follow-Up Results of Stage IA Invasive
Non-Small Cell Lung Cancer Patients.
Ann Surg Oncol. 2024 Jun 20. doi: 10.1245/s10434-024-15615. PubMed
KANZAKI R, Fukuda H, Kobayashi M, Horiguchi J, et al ASO Visual Abstract: Pathological Pleural Invasion is a Risk Factor for Late
Recurrence in Long-Term Survivors of Non-small Cell Lung Cancer After Complete
Resection.
Ann Surg Oncol. 2024 Jun 20. doi: 10.1245/s10434-024-15628. PubMed
LI X, Fan F, Yang Z, Huang Q, et al Ten-Year Follow-Up of Lung Cancer Patients with Resected Stage IA Invasive
Non-Small Cell Lung Cancer.
Ann Surg Oncol. 2024 Jun 18. doi: 10.1245/s10434-024-15572. PubMedAbstract available
BANSAL VV, Mitchell O, Drazer MW, Kindler HL, et al ASO Author Reflections: Venous Thromboembolism in Peritoneal Mesothelioma.
Ann Surg Oncol. 2024;31:3785-3786. PubMed
KOTI S, Demyan L, Deutsch G, Weiss M, et al Surgery for Oligometastatic Pancreatic Cancer: Defining Biologic Resectability.
Ann Surg Oncol. 2024;31:4031-4041. PubMedAbstract available
SHARMA J, Deo SVS, Kumar S, Bhoriwal S, et al Malignant Chest Wall Tumors: Complex Defects and Their Management-A Review of 181
Cases.
Ann Surg Oncol. 2024;31:3675-3683. PubMedAbstract available
May 2024
AL-KASSPOOLES M, Wilkerson J Is Radiomics Ready for Prime Time in Managing Non-small Cell Lung Cancer?
Ann Surg Oncol. 2024 May 18. doi: 10.1245/s10434-024-15406. PubMed
ISHIDA M, Mimae T, Kamigaichi A, Kawamoto N, et al The Role of Emphysema on Postoperative Prognosis in Early-Stage Nonsmall Cell
Lung Cancer.
Ann Surg Oncol. 2024 May 13. doi: 10.1245/s10434-024-15126. PubMedAbstract available
DENG HY, Zhou Q Pleural Invasion in Non-small Cell Lung Cancer: An Important Characteristic
during Clinical Decision-Making.
Ann Surg Oncol. 2024 May 8. doi: 10.1245/s10434-024-15401. PubMed
ISHIDA M, Mimae T, Okada M ASO Author Reflections: How Does Emphysema Contribute to Poor Prognosis After
Lung Cancer Surgery?
Ann Surg Oncol. 2024 May 8. doi: 10.1245/s10434-024-15171. PubMed
APRILE V, Ambrogi MC, Lucchi M Surgery in Stage IV Non-small Cell Lung Cancer: Good Time for a Chance.
Ann Surg Oncol. 2024 May 6. doi: 10.1245/s10434-024-15308. PubMed
YAN HJ, Zhao JS, Liu Q, Yang C, et al ASO Author Reflections: The Clinical Use of Dual-Region Radiomics-Based Machine
Learning in the Identification of Subcarinal Lymph Node Metastasis of Non-small
Cell Lung Cancer.
Ann Surg Oncol. 2024 May 6. doi: 10.1245/s10434-024-15271. PubMed
BANSAL VV, Mitchell O, Bregio C, Witmer HDD, et al Venous Thromboembolism in Peritoneal Mesothelioma: Uncovering the Hidden Risk.
Ann Surg Oncol. 2024;31:3339-3349. PubMedAbstract available
GRAUR A, Saenger JA, Mercaldo ND, Simon J, et al Multimodality Management of Thoracic Tumors: Initial Experience With a
Multidisciplinary Thoracic Ablation Conference.
Ann Surg Oncol. 2024;31:3426-3436. PubMedAbstract available
April 2024
SIRAKAYA F, Calik Kutukcu E, Onur MR, Dikmen E, et al The Effects of Various Approaches to Lobectomies on Respiratory Muscle Strength,
Diaphragm Thickness, and Exercise Capacity in Lung Cancer.
Ann Surg Oncol. 2024 Apr 28. doi: 10.1245/s10434-024-15312. PubMedAbstract available
KANZAKI R, Fukuda H, Kobayashi M, Horiguchi J, et al Pathological Pleural Invasion is a Risk Factor for Late Recurrence in Long-Term
Survivors of Non-small Cell Lung Cancer after Complete Resection.
Ann Surg Oncol. 2024 Apr 22. doi: 10.1245/s10434-024-15279. PubMedAbstract available
LIU J, Shi Z, Cao B, Wang Z, et al ASO Author Reflections: The Prognostic Significance of the Highest Mediastinal
Lymph Node Involvement in Non-small Cell Lung Cancer Patients.
Ann Surg Oncol. 2024 Apr 4. doi: 10.1245/s10434-024-15243. PubMed
SARVESTANI AL, Lambdin J, Hu M, Cabanillas M, et al Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancers.
Ann Surg Oncol. 2024;31:2202-2203. PubMed
CHATTERJEE A, Kusamura S, Baratti D, Guaglio M, et al ASO Author Reflections: Perioperative Systemic Chemotherapy in Diffuse Malignant
Peritoneal Mesothelioma treated with CRS-HIPEC.
Ann Surg Oncol. 2024;31:2511-2512. PubMed
SHIKANAI S, Yamada N, Yanagawa N, Sugai M, et al ASO Visual Abstract: Prognostic Impact of Tumor-Associated Macrophage-Related
Markers in Patients with Adenocarcinoma of the Lung.
Ann Surg Oncol. 2024;31:2521-2522. PubMed
March 2024
YAN HJ, Zhao JS, Zuo HD, Zhang JJ, et al Dual-Region Computed Tomography Radiomics-Based Machine Learning Predicts
Subcarinal Lymph Node Metastasis in Patients with Non-small Cell Lung Cancer.
Ann Surg Oncol. 2024 Mar 23. doi: 10.1245/s10434-024-15197. PubMedAbstract available
LIU J, Shi Z, Cao B, Wang Z, et al Prognostic Significance of the Highest Mediastinal Lymph Node Involvement in
Patients with Stage III-N2 Non-small Cell Lung Cancer.
Ann Surg Oncol. 2024 Mar 23. doi: 10.1245/s10434-024-15184. PubMedAbstract available
GRENDA TR Refocusing the Prognosis Lens: Conditional Survival After Surgery in
Limited-Stage Small Cell Lung Cancer.
Ann Surg Oncol. 2024 Mar 21. doi: 10.1245/s10434-024-15168. PubMed
PARK S, Choe J, Lee SM, Choi S, et al ASO Visual Abstract: Surgical Outcomes in Non-small Cell Lung Cancer with Distant
Metastasis: The Prognostic Significance of Delayed Metastasis Diagnosis.
Ann Surg Oncol. 2024 Mar 14. doi: 10.1245/s10434-024-15135. PubMed
LIN MW, Chen LW, Yang SM, Hsieh MS, et al ASO Visual Abstract: CT-Based Deep Learning Model for Spread Through Air Spaces
Prediction in Ground-Glass Predominant Lung Adenocarcinoma.
Ann Surg Oncol. 2024;31:1597-1598. PubMed
YOON DW, Hwang S, Hong TH, Choi YL, et al ASO Visual Abstract: Distinct Recurrence Pattern and Survival Outcomes of
Invasive Mucinous Adenocarcinoma of the Lung: The Potential Role of Local Therapy
in Intrapulmonary Spread.
Ann Surg Oncol. 2024;31:1591-1592. PubMed
PAN H, Huang J, Luo Q ASO Author Reflections: Should We Prefer Robotic over Thoracoscopic Surgery for
Sublobar Resection in Octogenarians with Pulmonary Nodules = 2 cm?
Ann Surg Oncol. 2024;31:1585-1586. PubMed
LIN MW, Chen LW, Yang SM, Hsieh MS, et al CT-Based Deep-Learning Model for Spread-Through-Air-Spaces Prediction in Ground
Glass-Predominant Lung Adenocarcinoma.
Ann Surg Oncol. 2024;31:1536-1545. PubMedAbstract available
February 2024
LIN JP, Liu SY, Wang F ASO Author Reflections: Conditional Survival of Patients with Limited-Stage Small
Cell Lung Cancer After Surgery-A National Real-World Cohort Study.
Ann Surg Oncol. 2024 Feb 23. doi: 10.1245/s10434-024-15062. PubMed
PARK S, Choe J, Lee SM, Choi S, et al Surgical Outcomes in Non-Small Cell Lung Cancer with Distant Metastasis: The
Prognostic Significance of Delayed Metastasis Diagnosis.
Ann Surg Oncol. 2024 Feb 22. doi: 10.1245/s10434-024-14984. PubMedAbstract available
LIN JP, Chen XF, Wang P, He H, et al Conditional Survival of Patients with Limited-Stage Small Cell Lung Cancer After
Surgery: A National Real-World Cohort Study.
Ann Surg Oncol. 2024 Feb 9. doi: 10.1245/s10434-024-14983. PubMedAbstract available
XU SJ, Chen C, Tu JH, You CX, et al ASO Visual Abstract: Dynamic Analysis of the Impact of Micropapillary Component
on Different Recurrence Patterns of Pathological Stage IA3 Lung Adenocarcinoma-A
Multicenter, Retrospective Study.
Ann Surg Oncol. 2024;31:906-907. PubMed
XU SJ, Chen C, Tu JH, You CX, et al Dynamic Analysis of the Impact of Micropapillary Component on Different
Recurrence Patterns of Pathological Stage IA3 Lung Adenocarcinoma: A Multicenter,
Retrospective Study.
Ann Surg Oncol. 2024;31:872-882. PubMedAbstract available
January 2024
KAZZI B, Mankuzhy NP, Swami N, Jain B, et al Surgical Resection Delays among Patients with Stage 1 Lung Cancer: A Study with
Disaggregated Ethnic Groups.
Ann Surg Oncol. 2024 Jan 28. doi: 10.1245/s10434-024-14952. PubMed
OKUYAMA A, Mizutani T, Tachibana K, Higashi T, et al ASO Visual Abstract: Treatment Patterns and Postoperative Activities of Daily
Living in Patients with Non-small Cell Lung Cancer-A Retrospective Study Using
Nationwide Health Services Utilization Data in Japan.
Ann Surg Oncol. 2024 Jan 24. doi: 10.1245/s10434-024-14928. PubMed
CHATTERJEE A, Kusamura S, Baratti D, Guaglio M, et al Impact of Perioperative Systemic Chemotherapy on Survival for Patients Who have
Diffuse Malignant Peritoneal Mesothelioma Treated with CRS-HIPEC.
Ann Surg Oncol. 2024;31:556-566. PubMedAbstract available
LI W, Yang Y, Yang M, Song N, et al Clinicopathologic Features and Survival Outcomes of Primary Lung Mucinous
Adenocarcinoma Based on Different Radiologic Subtypes.
Ann Surg Oncol. 2024;31:167-177. PubMedAbstract available
WOODARD GA, Cho C, Chen L Increased Lymphocyte Infiltration in NSCLC Neoadjuvant Chemo-Immunotherapy
Non-responders: A Biomarker of T-Cell Dysfunction and Prognosis?
Ann Surg Oncol. 2024;31:25-27. PubMed
YANG X, Xiao Y, Hu H, Qiu ZB, et al ASO Visual Abstract: Expression Changes in Programmed Death Ligand 1 from
Precancerous Lesions to Invasive Adenocarcinoma in Subcentimeter Pulmonary
Nodules-A Large Study of 2022 Cases in China.
Ann Surg Oncol. 2024;31:245-246. PubMed
YOON DW, Hwang S, Hong TH, Choi YL, et al Distinct Recurrence Pattern and Survival Outcomes of Invasive Mucinous
Adenocarcinoma of the Lung: The Potential Role of Local Therapy in Intrapulmonary
Spread.
Ann Surg Oncol. 2024;31:201-212. PubMedAbstract available
December 2023
MI J, Li C, Yang F, Shi X, et al ASO Visual Abstract: Comparative Study of Indocyanine Green Fluorescence Imaging
in Lung Cancer with Near-Infrared-I/II Windows.
Ann Surg Oncol. 2023 Dec 26. doi: 10.1245/s10434-023-14795. PubMed
PAN H, Zou N, Tian Y, Shen Y, et al ASO Visual Abstract: Robotic Versus Thoracoscopic Sub-lobar Resection for
Octogenarians with Clinical IA-Stage Non-small Cell Lung Cancer: A Propensity
Score-Matched Real-World Study.
Ann Surg Oncol. 2023 Dec 22. doi: 10.1245/s10434-023-14799. PubMed
OKUYAMA A, Mizutani T, Tachibana K, Higashi T, et al Treatment Patterns and Postoperative Activities of Daily Living in Patients with
Non-small Cell Lung Cancer: A Retrospective Study Using Nationwide Health
Services Utilization Data in Japan.
Ann Surg Oncol. 2023 Dec 21. doi: 10.1245/s10434-023-14798. PubMedAbstract available
DIAO H, Xu L, Li X, Wang Y, et al Comparison Results of Three-Port Robot-Assisted and Uniportal Video-Assisted
Lobectomy for Functional Recovery Index in the Treatment of Early Stage Non-small
Cell Lung Cancer: A Propensity Score-Matched Analysis.
Ann Surg Oncol. 2023 Dec 17. doi: 10.1245/s10434-023-14767. PubMedAbstract available
PAN H, Zou N, Tian Y, Shen Y, et al Robotic Versus Thoracoscopic Sub-lobar Resection for Octogenarians with Clinical
Stage IA Non-small Cell Lung Cancer: A Propensity Score-Matched Real-World Study.
Ann Surg Oncol. 2023 Dec 10. doi: 10.1245/s10434-023-14689. PubMedAbstract available
MI J, Li C, Yang F, Shi X, et al Comparative Study of Indocyanine Green Fluorescence Imaging in Lung Cancer with
Near-Infrared-I/II Windows.
Ann Surg Oncol. 2023 Dec 8. doi: 10.1245/s10434-023-14677. PubMedAbstract available
KINOSHITA F, Takada K, Wakasu S, Saito S, et al ASO Visual Abstract: Granzyme B (GZMB)-Positive Tumor-Infiltrating Lymphocytes in
Lung Adenocarcinoma: Significance as a Prognostic Factor and Association With
Immunosuppressive Proteins.
Ann Surg Oncol. 2023;30:8290-8291. PubMed
November 2023
MACHADO PFA, Oliveiros B, Martins RA, Cruz J, et al ASO Author Reflections: Impact of a Preoperative Home-Based Exercise Program on
Quality of Life After Lung Cancer Resection.
Ann Surg Oncol. 2023 Nov 19. doi: 10.1245/s10434-023-14620. PubMed
MACHADO PFA, Pimenta S, Garcia AL, Nogueira T, et al ASO Visual Abstract: Effect of Preoperative Home-Based Exercise Training on
Quality of Life After Lung Cancer Surgery: A Multicenter Randomized Controlled
Trial.
Ann Surg Oncol. 2023 Nov 17. doi: 10.1245/s10434-023-14602. PubMed
MACHADO P, Pimenta S, Garcia AL, Nogueira T, et al Effect of Preoperative Home-Based Exercise Training on Quality of Life After Lung
Cancer Surgery: A Multicenter Randomized Controlled Trial.
Ann Surg Oncol. 2023 Nov 7. doi: 10.1245/s10434-023-14503. PubMedAbstract available
YANG X, Xiao Y, Hu H, Qiu ZB, et al Expression Changes in Programmed Death Ligand 1 from Precancerous Lesions to
Invasive Adenocarcinoma in Subcentimeter Pulmonary Nodules: A Large Study of 2022
Cases in China.
Ann Surg Oncol. 2023;30:7400-7411. PubMedAbstract available
KEPENEKIAN V, Sgarbura O, Marchal F, Villeneuve L, et al ASO Author Reflections: International Standardization of Hyperthermic
Intraperitoneal Chemotherapy (HIPEC) Protocols-Malignant Peritoneal Mesothelioma
as a Model.
Ann Surg Oncol. 2023;30:7858-7859. PubMed
VILLENA-VARGAS J Sowing the Seeds of Evasion: Lung Adenocarcinoma Plans Its Escape.
Ann Surg Oncol. 2023;30:6972-6973. PubMed
KEPENEKIAN V, Sgarbura O, Marchal F, Villeneuve L, et al 2022 PSOGI Consensus on HIPEC Regimens for Peritoneal Malignancies: Diffuse
Malignant Peritoneal Mesothelioma.
Ann Surg Oncol. 2023;30:7803-7813. PubMedAbstract available
KOSAI K, Masuda T, Kitagawa A, Tobo T, et al Transducin Beta-Like 2 is a Potential Driver Gene that Adapts to Endoplasmic
Reticulum Stress to Promote Tumor Growth of Lung Adenocarcinoma.
Ann Surg Oncol. 2023;30:7538-7548. PubMedAbstract available
SHIKANAI S, Yamada N, Yanagawa N, Sugai M, et al Prognostic Impact of Tumor-Associated Macrophage-Related Markers in Patients with
Adenocarcinoma of the Lung.
Ann Surg Oncol. 2023;30:7527-7537. PubMedAbstract available
October 2023
RUCK JM, Broderick SR Neoadjuvant and Adjuvant Pembrolizumab for the Treatment of Early-Stage
Resectable Non-small Cell Lung Cancer An Editorial Regarding the Interim Data
Analysis of the KEYNOTE-671 Phase III Trial of Neoadjuvant and Adjuvant
Pembrolizumab.
Ann Surg Oncol. 2023 Oct 26. doi: 10.1245/s10434-023-14356. PubMed
SWANSON SJ Difficulty of Video-Assisted Thoracoscopic Surgery Segmentectomy: Proposal for a
New Classification System-All "Segmentectomies" Are Not Created Equal.
Ann Surg Oncol. 2023;30:6315. PubMed
YAO F, Wu W, Zhu Q, Zhu Y, et al ASO Visual Abstract: Difficulty of Video-Assisted Thoracoscopic Surgery
Segmentectomy: Proposal for a New Classification.
Ann Surg Oncol. 2023;30:6717. PubMed
ALEXANDER HR Perioperative Systemic Chemotherapy in Patients with Malignant Peritoneal
Mesothelioma Undergoing Cytoreduction and HIPEC: Don't Put the Cart Before the
Horse.
Ann Surg Oncol. 2023;30:6301-6303. PubMed
YAO F, Wu W, Zhu Q, Zhu Y, et al Difficulty of Video-Assisted Thoracoscopic Surgery Segmentectomy: Proposal for a
New Classification.
Ann Surg Oncol. 2023;30:6707-6716. PubMedAbstract available
September 2023
MATSUDA N, Yamamoto H, Habu T, Iwata K, et al ASO Visual Abstract: Prognostic Impact of Tumor-Infiltrating Lymphocytes,
Tertiary Lymphoid Structures, and Neutrophil-to-Lymphocyte Ratio in Pulmonary
Metastases from Uterine Leiomyosarcoma.
Ann Surg Oncol. 2023 Sep 27. doi: 10.1245/s10434-023-14311. PubMed
FU F, Zhang Y, Chen H ASO Author Reflections: Upfront Surgery Followed by Adjuvant Therapy: An Option
for IIIA-N2 Non-small Cell Lung Cancer.
Ann Surg Oncol. 2023 Sep 27. doi: 10.1245/s10434-023-14265. PubMed
MATSUDA N, Yamamoto H, Habu T, Iwata K, et al Prognostic Impact of Tumor-Infiltrating Lymphocytes, Tertiary Lymphoid
Structures, and Neutrophil-to-Lymphocyte Ratio in Pulmonary Metastases from
Uterine Leiomyosarcoma.
Ann Surg Oncol. 2023 Sep 1. doi: 10.1245/s10434-023-14176. PubMedAbstract available